These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12066223)

  • 1. Sarcoma and thyroid disorders: a common etiology?
    Merimsky O; Issakov J; Kollender Y; Inbar M; Bickels J; Meller I
    Oncol Rep; 2002; 9(4):863-9. PubMed ID: 12066223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
    Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
    Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An identical effect mediated by thyroid deficiency or oncogene v-erbA in the chick embryo.
    Bachnou N; Saule S; Dieterlen-Lievre F
    Int J Dev Biol; 1996 Apr; 40(2):491-7. PubMed ID: 8793620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
    Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
    Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimerization of v-erbA on inverted repeats.
    Zubkova I; Subauste JS
    Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
    Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC
    Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptor, v-ErbA, and chromatin.
    Wolffe AP; Collingwood TN; Li Q; Yee J; Urnov F; Shi YB
    Vitam Horm; 2000; 58():449-92. PubMed ID: 10668407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ferritin mRNA translation in primary erythroblasts: exogenous c-Kit plus EpoR signaling mimics v-ErbA oncoprotein activity.
    Mikulits W; Schranzhofer M; Deiner EM; Beug H; Müllner EW
    Biochem Biophys Res Commun; 2000 Aug; 275(2):292-4. PubMed ID: 10964660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endogenous signal triggering erythroid differentiation: identification as thyroid hormone.
    Dinnen RD; White SR; Elsayed S; Yeh YI; Ebisuzaki K
    Cell Growth Differ; 1994 Aug; 5(8):855-61. PubMed ID: 7986750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor mutations in cancer.
    Cheng SY
    Mol Cell Endocrinol; 2003 Dec; 213(1):23-30. PubMed ID: 15062571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
    Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
    Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the DNA binding specificity and function of v-ErbA and thyroid hormone receptor alpha 1.
    Subauste JS; Koenig RJ
    J Biol Chem; 1995 Apr; 270(14):7957-62. PubMed ID: 7713893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.